Healthcare Triangle Inc
For the period ended Mar 31, 2024. Filed May 20, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 20, 2024
HCTI$4.21-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Cash Flows
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In thousands) | ||
| Cash flows from operating activities | ||
| Net income (loss) | $(1,862) | $(3,278) |
| Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities | ||
| Depreciation | 11 | 17 |
| Amortization | 335 | 857 |
| Warrant liability | 190 | |
| Common stock issued for services | — | 51 |
| Amortization of debt discount | 36 | — |
| Stock compensation expenses | 26 | 142 |
| Changes in operating assets and liabilities: | ||
| (Increase)/ decrease in: | ||
| Accounts receivable | 1,141 | 80 |
| Other current assets | 486 | 155 |
| Due from related party | 271 | (276) |
| Increase/ (decrease) in: | ||
| Accounts payable and accrued expenses | 60 | (174) |
| Other current liabilities | (744) | 823 |
| Payment of lease liability | ||
| Net cash provided by/ (used in) operating activities | (50) | (1,603) |
| Cash flows from investing activities | ||
| (Purchase)/sale of property and equipment | — | (4) |
| Increase in intangible assets | ||
| Net cash provided by/ (used in) investing activities | — | (4) |
| Cash flows from financing activities | ||
| Increase/(decrease) in short term borrowing | (883) | 533 |
| Repurchases of common stock | ||
| Increase in additional paid-up capital | — | |
| Net cash provided by/ (used in) financing activities | (883) | 533 |
| Net increase (decrease) in cash and cash equivalents | (933) | (1,074) |
| Cash and cash equivalents | ||
| Cash and cash equivalents at the beginning of the period | $1,234 | $1,341 |
| Cash and cash equivalents at the end of the period | $301 | $267 |
| Non-cash investing and financing activities | ||
| Conversion of debt into common stock | 787 | — |
| Supplementary disclosure of cash flows information | ||
| Interest | 149 | 62 |
| Income taxes | 5 | 19 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.